Earnings call Sunny Optical delivered robust FY2025 results with revenue up 12.9% YoY to RMB 43.23 billion and net profit attributable to shareholders surging 71.9% YoY to RMB 4.64 billion. Margin ...

Leadville ultrarunner Courtney Dauwalter secured her fourth Hardrock 100 title on Saturday with another magical stroll ...

ASP.NET has been a workhorse of business software for more than two decades. Banks run their transaction systems on it, insurance companies ...

Nitasha Shankar Back in 2014, I came across what I'll call Company A. It wasn't in the headlines. It wasn't part of anyone's "Top 10 Ideas" list. In fact, most institutional desks weren't even ...

NCS today announced an expanded Sunshine.AI suite of sovereign, enterprise-grade AI platforms and products, formed new sector-specific partnerships, and committed to training next-generation AI talent ...

Extended Studies students learn industry best practices to navigate and elevate their careers in management and Lean Six ...

Classic towers, sleek all-in-ones, space-saving mini PCs: Today's desktops pack neater designs and more value than ever. See our recent favorites based on our deep-dive reviews, plus all the shopping ...

Bluehost is a feature-rich web host that has numerous e-commerce add-ons and a WordPress-enhancing AI tool that gives the popular CMS even more flexibility. Before delving into Bluehost's top-tier ...

The International Criminal Court is in an unprecedented state of limbo. Its chief prosecutor, Karim Khan, has been suspended amid a campaign to remove him from office. Member states of the bureau of ...

ASP Isotopes is rated Sell due to premature growth narrative, high capital intensity, and heavy execution risk versus the current $6.89 share price. My DCF valuation implies a $2.40 fair value, ...

Delivered Net Sales of $99.5 million in the first quarter, at the high end of guidance range and exceeding analyst consensus Total orders and AOV each grew year-over-year 3% Average Selling Price (ASP ...

Earnings call GeneDx (WGS) posted Q1 2026 revenues of $102.3M, with exome/genome volumes up 34% YoY, but total revenue missed expectations by $12M due to lower blended reimbursement rates and softer ...